Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Th1-type cytokines are a group of pro-inflammatory cytokines predominantly produced by T helper type 1 (Th1) cells, a subset of CD4+ T lymphocytes central to the immune response against intracellular pathogens such as viruses and certain bacteria[1][2][3][4]. The principal Th1 cytokines are interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and interleukin-2 (IL-2)[1][2][3]. These cytokines activate macrophages, enhance antigen presentation, and promote cytotoxic T lymphocyte responses, collectively driving cell-mediated immunity[1][3][4]. While Th1 activity is vital for pathogen clearance, excessive or dysregulated Th1 cytokine production is implicated in the pathogenesis of several autoimmune and chronic inflammatory diseases, including type 1 diabetes mellitus, multiple sclerosis, rheumatoid arthritis, Crohn’s disease, and others[1][3][4]. Th1-type cytokines are not a single molecular target or receptor but rather a functionally related group of signaling proteins involved in immune regulation. Note: This entry is marked as is_incorrect: true, because "Th1-type cytokines" is *not* a specific molecule or receptor but rather a functional category comprising several cytokines (e.g., IFN-γ, TNF-α, IL-2). For structured information aligned to individual drug targets, it is necessary to specify the particular cytokine (e.g., Interferon-gamma) rather than the generic “Th1-type cytokines” grouping[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T helper type 1 cytokine (Th1 cytokine).